Physicians’ Education Resource®, LLC (PER®), will host the 2018 New York
Cardio-Endo-Renal Collaborative (NY CERC) on September 29, 2018, at the
Westin New York Grand Central in New York City. The program will be
chaired by James Underberg, M.D., FACPM, FACP, FNLA, immediate
past president of the National Lipid Association, clinical assistant
professor of medicine, New York University School of Medicine. This
educational event will discuss latest innovations and advancements to
treat and manage metabolic and cardiovascular diseases (CVDs).
“Cardiovascular and metabolic diseases can be challenging to treat
alone, yet more and more patients present with comorbid disease that can
make management exponentially difficult,” said Phil Talamo, president of
PER®. “New management guidelines from the American Heart Association,
American College of Cardiology, and the American Diabetes Association
address the need for more aggressive treatment approaches for these
patients. This program will provide updates on these new guidelines,
discuss new medications that can benefit patients across the continuum
of cardiometabolic disease, and share best practices on how to optimally
manage these complex patients.”
The following co-chairs will join Underberg during the conference:
NY CERC is a 1-day educational conference that focuses on emerging and
novel approaches to integrated cardiometabolic disease management.
During the program, attendees will gain insight into CVD prevention,
diabetes, obesity management and lipid management, and other
cardiometabolic risk factors. The conference will also delve into the
multifaceted and individualized strategies designed to attain treatment
goals and enhance patient outcomes.
This program is accredited by the Accreditation Council for Continuing
Medical Education, and attendees are eligible for a maximum of 6.0 AMA
PRA Category 1 Credit™. For more information and registration, visit https://www.gotoper.com/non-onc-conferences/cerc/meetings/2nd-annual-multidisciplinary-cardio-endo-renal-collaborative.
About PER®:
Since 1995, PER® has been dedicated to advancing cancer care through
professional education and now furthers patient care and treatment
strategies on a wide variety of chronic illnesses and diseases. In 2016,
PER® initiated continuing medical education (CME) programming in the
cardiovascular and endocrinology areas and continues to grow its’
therapeutic reach outside of oncology. While continuing to expand into
other nononcology topics, PER® remains the leading provider of live,
online, and print CME activities focusing on oncology and hematology by
providing high-quality, evidence-based activities featuring leading
distinguished experts who focus on the application of practice-changing
advances. In 2018, PER® will develop and implement 21 historic annual
legacy conferences in the United States and Europe, along with many
renowned online learning formats. PER® is accredited by the ACCME and
CBRN. PER® is part of the Cranbury, New Jersey-based MJH Associates,
Inc. family of businesses. Learn more at http://www.gotoper.com
and http://www.mjhassoc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180801005919/en/